Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 156 participants.

Also called NCT01776788

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 156 participants (enrolled count) (from the registry)
Sponsor
The First Affiliated Hospital of Xiamen University (from the registry)
Registry
  • NCT NCT01776788
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01776788. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2015-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
insulin lispro injection, exenatide injection
Intervention (Drug)
insulin lispro injection
Lead sponsor
The First Affiliated Hospital of Xiamen University (class: other)

Record details

Record id
cardio:ct-nct01776788
Content hash
e50ade43b3798bb21943f4b594ec27d713e0a30db0d02ae1712a000814c5b3d8